1.

Record Nr.

UNISA996385417403316

Autore

Harington John, Sir, <1560-1612.>

Titolo

A briefe view of the state of the Church of England as it stood in Q. Elizabeths and King James his reigne, to the yeere 1608 [[electronic resource] ] : being a character and history of the bishops of those times ... / / written ... by Sir John Harington ..., Knight

Pubbl/distr/stampa

London, : Printed for Jos. Kirton ..., 1653

Descrizione fisica

[11], 211 [i.e. 213], [3] p

Altri autori (Persone)

ChetwyndJohn <1623-1692.>

Soggetti

Bishops - England

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

"The epistle dedicatory" signed: John Chetwind.

Reproduction of original in Union Theological Seminary Library, New York.

Includes index.

Sommario/riassunto

eebo-0160



2.

Record Nr.

UNINA9910628793303321

Autore

Mantegazza, Paolo <1829-1910>

Titolo

Elementi d'igiene / Paolo Mantegazza

Pubbl/distr/stampa

Sesto S. Giovanni, : Madella, 1912

Descrizione fisica

301 p. ; 19 cm

Locazione

FLFBC

Collocazione

5/XI <B> 10

Lingua di pubblicazione

Italiano

Formato

Materiale a stampa

Livello bibliografico

Monografia

3.

Record Nr.

UNINA9910139613803321

Autore

Kazmierski Wieslaw M

Titolo

Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials

Pubbl/distr/stampa

Hoboken, : Wiley, 2011

ISBN

1-283-20363-4

9786613203632

0-470-92935-9

0-470-92934-0

Descrizione fisica

1 online resource (470 p.)

Disciplina

615/.7924

Soggetti

Antiviral Agents -- therapeutic use

Antiviral agents

Clinical Trials as Topic

Drug Discovery

Drug Evaluation

Epidemiologic Studies

Chemistry, Pharmaceutical

Evaluation Studies as Topic

Investigative Techniques

Anti-Infective Agents

Epidemiologic Methods

Pharmacology

Therapeutic Uses



Health Care Evaluation Mechanisms

Chemistry

Biological Science Disciplines

Natural Science Disciplines

Quality of Health Care

Public Health

Pharmacologic Actions

Environment and Public Health

Health Care Quality, Access, and Evaluation

Chemical Actions and Uses

Health Care

Antiviral Agents

Health & Biological Sciences

Pharmacy, Therapeutics, & Pharmacology

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di contenuto

ANTIVIRAL DRUGS; CONTENTS; CONTRIBUTORS; PREFACE; PART I HUMAN IMMUNODEFICIENCY VIRUS; 1 Discovery and Development of Atazanavir; 2 Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor; 3 Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients; 4 Discovery and Development of Tipranavir; 5 TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients; 6 Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients

7 Discovery and Development of Tenofovir Disoproxil Fumarate8 Discovery and Development of Apricitabine; 9 Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection; 10 Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection; 11 Discovery and Development of HIV-1 Entry Inhibitors That Target gp120; 12 Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation; 13 Discovery and Development of HIV Integrase Inhibitor Raltegravir

14 Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer InhibitorPART II HEPATITIS C VIRUS; 15 Discovery and Development of Telaprevir; 16 Discovery and Development of BILN 2061 and Follow-up BI 201335; 17 Intervention of Hepatitis C Replication Through NS3-4A, the Protease Inhibitor Boceprevir; 18 Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227); 19 Discovery and Development of the HCV Protease Inhibitor TMC435; 20 Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection

21 Discovery and Development of PSI-6130/RG712822 Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV; 23 HCV Viral Entry Inhibitors; PART III RESPIRATORY SYNCYTIAL VIRUS INHIBITORS; 24 Discovery of the RSV Inhibitor TMC353121; 25



Discovery and Development of Orally Active RSV Fusion Inhibitors; 26 Discovery and Development of RSV604; PART IV INFLUENZA, HEPATITIS B, AND CYTOMEGALOVIRUS INHIBITORS; 27 Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza; 28 Discovery and Development of Entecavir

29 Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus DiseasesINDEX; Color Plate

Sommario/riassunto

This book focuses on new small molecule approaches to combat viral infections. The chapters describe the discovery and development from bench through the clinic of relatively recently-approved antiviral drugs and compounds in advanced clinical development. Organized by a virus (such as HIV, HCV, RSV, influenza, HBV and CMV) and written by top academic and industrial authorities in the field, the book provides a unique opportunity to study, understand and apply discovery and development principles and learning without the need for an individual to research, analyze and synthesize all immense so

4.

Record Nr.

UNINA9910251396303321

Autore

Hudson Martyn

Titolo

Centaurs, Rioting in Thessaly: Memory and the Classical World / Martyn Hudson

Pubbl/distr/stampa

Brooklyn, NY, : punctum books, 2018

Santa Barbara, CA : , : Punctum Books, , 2017

©2017

ISBN

1-947447-41-6

Edizione

[1st edition.]

Descrizione fisica

1 online resource (xviii, 98 pages) : illustrations; PDF, digital file(s)

Disciplina

292.13

Soggetti

Ancient Greek religion & mythology

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Nota di bibliografia

Includes bibliographical references.

Nota di contenuto

Introduction: Centaurs, rioting at Thessaly -- Never never lands -- Looking for centaurs -- Surveying the labyrinth -- Daedalus and his machines -- Ghosts, reading, and repetition -- Conclusion: Centaurs,



human and non-human.

Sommario/riassunto

This book treads new paths through the labyrinths of our human thought. It meanders through the darkness to encounter the monsters at the heart of the maze: Minotaurs, Centaurs, Automata, Makers, Humans. One part of our human thought emerges from classical Ionia and Greek civilisation more generally. We obsessively return to that thought, tread again its pathways, re-enact its stories, repeat its motifs and gestures. We return time and time again to construct and re-construct the beings which were part of its cosmology and mythology – stories enacted from a classical world which is itself at once imaginary and material.  The “Never Never Lands” of the ancient world contain fabulous beasts and humans and landscapes of desire and violence. We encounter the rioting Centaurs there and never again cease to conjure them up time and time again through our history. The Centaur mythologies display a fascination with animals and what binds and divides human beings from them. The Centaur hints ultimately at the idea of the genesis of civilisation itself.  The Labyrinth, constructed by Daedalus, is itself a prison and a way of thinking about making, designing, and human aspiration. Designed by humans it offers mysteries that would be repeated time and time again – a motif which is replicated through human history. Daedalus himself is an archetype for creation and mastery, the designer of artefacts and machines which would be the beginning of forays into the total domination of nature.  Centaurs, Labyrinths, Automata offer clues to the origins and ultimately the futures of humanity and what might come after it.